Latest Articles

Prognostic impact of achieving LDL cholesterol guidelines

Perceptions and Barriers on the use of PCSK9 inhibitors

LDL-C The Only Causal Risk Factor for ASCVD

Why low-density lipoprotein-cholesterol, the only causal risk factor for atherosclerotic cardiovascular disease, is still overlooked and underestimated.

LDL-C Targets in Patients with Heterozygous Familial Hypercholesterolemia

PCSK9 Inhibitors in Real World Practice

Closed-loop insulin delivery during exercise in people with T1DM

Lipid-lowering therapy and care gap in patients with Familial Hypercholesterolemia

PCSK9 inhibitors and ACS

Management of athletes and active people with diabetes - The American Medical Society for Sports Medicine (AMSSM) scientific statement